Abide Therapeutics

OverviewSuggest Edit

Our mission is to develop innovative medicines for the benefit of human health that target serine hydrolases, one of the largest enzyme classes in Nature with validated, but mostly untapped therapeutic potential. Hundreds of serine hydrolases exist in humans and include lipases, amidases, esterases, thioesterases, proteases and peptidases, which all share a base-activated serine nucleophile that cleaves an amide or ester bond. Serine hydrolases play a key role in regulating CNS signaling, digestion, metabolism, inflammation, blood clotting, life cycle of viruses and pathogens. The Abide technology selectively and near-universally targets this enzyme class in their native configuration for functional profiling and inhibitor discovery and optimization.
TypePrivate
Founded2011
HQSan Diego, US
Websiteabidetx.com

Latest Updates

Employees (est.) (Jun 2019)47(+3%)

Key People/Management at Abide Therapeutics

Alan Ezekowitz

Alan Ezekowitz

President, Co-Founder, CEO
Stan Blackburn

Stan Blackburn

CFO
Show more

Abide Therapeutics Office Locations

Abide Therapeutics has offices in San Diego and Princeton
San Diego, US (HQ)
10835 Rd to the Cure #250
Princeton, US
230 Nassau St
Show all (2)

Abide Therapeutics Financials and Metrics

Summary Metrics

Founding Date

2011

Abide Therapeutics total Funding

$2.3 m

Abide Therapeutics latest funding size

$2.25 m

Time since last funding

8 years ago
Abide Therapeutics's latest funding round in November 2011 was reported to be $2.3 m. In total, Abide Therapeutics has raised $2.3 m
Show all financial metrics

Abide Therapeutics Online and Social Media Presence

Embed Graph

Abide Therapeutics News and Updates

Neuropathic Pain - Pipeline Review including key players AbbVie Inc, Abide Therapeutics Inc, Acadia Pharmaceuticals Inc, Achelios Therapeutics

Neuropathic pain, or neuralgia, is a condition in which the sensory system is affected. It is commonly accompanied by tissue injury. Posted via Industry Today. Follow us on Twitter @IndustryToday

Abide Therapeutics Frequently Asked Questions

  • When was Abide Therapeutics founded?

    Abide Therapeutics was founded in 2011.

  • Who are Abide Therapeutics key executives?

    Abide Therapeutics's key executives are Alan Ezekowitz and Stan Blackburn.

  • How many employees does Abide Therapeutics have?

    Abide Therapeutics has 47 employees.

  • Who are Abide Therapeutics competitors?

    Competitors of Abide Therapeutics include Bausch Health Companies, Horizon Therapeutics and BioDelivery Sciences International.

  • Where is Abide Therapeutics headquarters?

    Abide Therapeutics headquarters is located at 10835 Rd to the Cure #250, San Diego.

  • Where are Abide Therapeutics offices?

    Abide Therapeutics has offices in San Diego and Princeton.

  • How many offices does Abide Therapeutics have?

    Abide Therapeutics has 2 offices.